title: Pathogenic effects of a novel heterozygous R350P desmin mutation on the assembly of desmin intermediate filaments in vivo and in vitro.
abstract: Mutations of the human desmin gene on chromosome 2q35 cause a familial or sporadic form of skeletal myopathy frequently associated with cardiac abnormalities. Here, we report the pathogenic effects of a novel heterozygous R350P desmin missense mutation, which resides in the evolutionary highly conserved coil 2B domain of the alpha-helical coiled-coil desmin rod domain, on the assembly of desmin intermediate filaments (IF) in cultured cells and in vitro. By transfection experiments, we show that R350P desmin is incapable of de novo formation of a desmin IF network in vimentin-free BMGE+H, MCF7 and SW13 cells and that it disrupts the endogenous vimentin cytoskeleton in 3T3 fibroblast cells. Hence, transfected cells displayed abnormal cytoplasmic protein aggregates reminiscent of desmin-positive protein deposits seen in the immunohistochemical and ultrastructural analysis of skeletal muscle derived from the index patient of the affected family. To study the functional effects of the R350P desmin mutation at the protein level, we performed in vitro assembly studies with wild-type (WT) and mutant desmin protein. Our analysis revealed that the in vitro assembly process of R350P desmin is already disturbed at the unit length filament level and that further association reactions generate huge, tightly packed protein aggregates. On assessing the pathogenic effects of R350P desmin in various mixtures with WT desmin, we show that a ratio of 1 : 3 (R350P desmin/WT desmin) is sufficient to effectively block the normal polymerization process of desmin IFs. Our findings indicate that the heterozygous R350P desmin mutation exerts a dominant negative effect on the ordered lateral arrangement of desmin subunits. This disturbance of the lateral packing taking place in the first phase of assembly is ultimately leading to abnormal protein aggregation.
authors.affiliation: Department of Cell Biology, German Cancer Research Center (DKFZ), Heidelberg.
authors.forename: Harald
authors.initials: H
authors.lastname: Bär
authors.forename: Dirk
authors.initials: D
authors.lastname: Fischer
authors.forename: Bertrand
authors.initials: B
authors.lastname: Goudeau
authors.forename: Rudolf A
authors.initials: RA
authors.lastname: Kley
authors.forename: Christoph S
authors.initials: CS
authors.lastname: Clemen
authors.forename: Patrick
authors.initials: P
authors.lastname: Vicart
authors.forename: Harald
authors.initials: H
authors.lastname: Herrmann
authors.forename: Matthias
authors.initials: M
authors.lastname: Vorgerd
authors.forename: Rolf
authors.initials: R
authors.lastname: Schröder
mesh_terms: D016475:3T3 Cells; D000818:Animals; D001120:Arginine / Q000235:genetics; D004252:DNA Mutational Analysis; D003893:Desmin / Q000235:genetics* / Q000378:metabolism; D005260:Female; D005455:Fluorescent Antibody Technique; D006580:Genetic Carrier Screening; D006801:Humans; D007150:Immunohistochemistry; D007382:Intermediate Filaments / Q000235:genetics* / Q000378:metabolism; D008297:Male; D051379:Mice; D008854:Microscopy, Electron; D018482:Muscle, Skeletal / Q000473:pathology / Q000648:ultrastructure; D009154:Mutation; D010375:Pedigree; D011392:Proline / Q000235:genetics; D014162:Transfection
chemical_list: D003893:Desmin; D001120:Arginine; D011392:Proline